University of New Mexico
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of New Mexico sits in the top decile of US sponsors by registered trial count (#172 of 15,742 sponsors by registered trial count).
University of New Mexico: 168 sponsored US clinical trials, 2 recruiting.
University of New Mexico sponsors 168 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 123 completed. 15 of these trials are in Phase 3-4 (later-stage) and 25 in Phase 1-2 (earlier-stage).
Top-decile sponsor footprint
University of New Mexico ranks in the top decile of sponsors by registered trial count (#172 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
123 of 165 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (74.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
168 total, page 2 of 4
Neurocognitive and Neurobehavioral Mechanisms of Change Following Psychological Treatment for Alcohol Use Disorder
NCT03842670
Nexus of Risk: Sexual Assault, Alcohol Use, and Risky Sex Among College Women
NCT05892692
Pain Relief Satisfaction With New Educational Materials
NCT03698773
Peripherally Inserted Internal Jugular Catheters: an Observational Study
NCT03523533
High-Definition Transcranial Direct Current Stimulation (HD-tDCS) for Sensory Deficits in Complex Traumatic Brain Injury
NCT03799458
Systematized Quality Exercise Alternatives for Stress Incontinence
NCT03443687
Zero Suicide Plus KICKS
NCT03924037
Adverse Childhood Experiences in Urogynecologic Patients
NCT03480477
Developing Community Partnerships Through Research to Define Community Well-Being With Three (Diné) Navajo Communities
NCT05937087
Immigrant Well-being Project: Transdisciplinary Ecological Mental Health Intervention for Mexican Immigrants
NCT03926247
Mild Encephalopathy in the Newborn Treated With Darbepoetin
NCT03071861
Perspectives on Prescribing Hormonal Contraception Among Rural New Mexicans
NCT03230578
Stroke and Cerebrovascular Diseases Registry
NCT03281590
A Double-Blind, Placebo-Controlled Trial of Anti-Aging, Pro-Autophagy Effects of Metformin in Adults With Prediabetes
NCT03309007
Home-Based Kidney Care in Native American's of New Mexico (HBKC)
NCT03179085
Abo Follow-up Study
NCT03243513
Testing Effectiveness of the Community Reinforcement Approach and Family Training (CRAFT) With American Indians
NCT03203889
Evaluation of Immediate Postpartum LARC Implementation Programs
NCT03118726
Patient Preferences in Anesthesia for Abortion Care
NCT03030443
Compass Device CVC Trial
NCT03056859
Comparing Program Options for Latinos With Diabetes
NCT03004664
Diuretic/Cool Dialysate Trial
NCT02593526
Mindfulness-Based Intervention and Transcranial Direct Current Brain Stimulation to Reduce Heavy Drinking
NCT02861807
Enhancing Prevention Pathways Toward Tribal Colorectal Health
NCT02882620
ECT Pulse Amplitude and Medial Temporal Lobe Engagement
NCT02999269
Morphine Versus Methadone for Opiate Exposed Infants With Neonatal Abstinence Syndrome
NCT02851303
Visits Versus Telephone Calls for Postoperative Care
NCT02891187
Effect of Acetaminophen on Postpartum Blood Pressure Control in Preeclampsia With Severe Features
NCT02911701
Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
NCT02893371
Nitrous Oxide Versus Intravenous Sedation for Anesthesia
NCT02755090
We Experience: Perspectives on a Quality Abortion Care Experience: A Patient Centered Approach
NCT02827474
Naloxone Auto-injector as a Universal Precaution for Patients With Opioid Use Disorder
NCT02669901
Quantitative Genioglossal Muscle Strength in Obstructive Sleep Apnea (OSAS)
NCT02695667
Brief Intervention for Teen Pregnancy Prevention
NCT02816424
Perioperative Aspirin Usage Survey
NCT02561507
Transcranial Direct Current Stimulation for the Treatment of Deficits After Traumatic Brain Injury
NCT02613936
Visual Activity Evoked by Infrared in Humans After Dark Adaptation
NCT02909985
Skin Health Online for Melanoma: Better Risk Assessment
NCT03130569
Spreading Depolarization and Ketamine Suppression
NCT02501941
Chlorhexidine Cord Care for Newborn Infants in Kenya
NCT02624622
Mindfulness-Based Therapy for Interstitial Cystitis/Bladder Pain Syndrome
NCT02457182
Running Study for Runners With Chronic Knee Pain
NCT02567123
Mentored Research on Improving Alcohol Brief Interventions in Medical Settings
NCT02978027
Ferumoxytol-enhanced Imaging of Osteomyelitis
NCT05959590
ACTION PAC: Adolescents Committed to Improvement of Nutrition & Physical Activity
NCT02502383
Postplacental Intrauterine Device Insertion: A Mixed Methods Assessment of Women's Experience
NCT02312726
Nitrous Oxide for Pain Management of Intrauterine Device (IUD) Insertion
NCT02391714
Neural Mechanisms of Change During the Treatment of Alcohol Use Disorders With Prazosin
NCT01916941
Brain-Centered Therapy Versus Medication for Urgency Urinary Incontinence : Hypnotherapy Or Pharmacotherapy
NCT01829425
Identification of Optimal Stimulation Site for Cervical Dystonia Symptoms: An Exploratory Study
NCT01859247
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 14 |
| Phase 2 | 11 |
| Phase 3 | 4 |
| Phase 4 | 11 |
What is open in the University of New Mexico pipeline
2 recruiting of 168 indexed (1% open); 123 completed (73%).
Phase mix: 15 late (III/IV) vs 25 early (I/II) (early-phase heavy).
Therapeutic area indexing for this sponsor is limited in the public registry.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of New Mexico: open-pipeline peers nationwide
Peers matched on 168 registered trials and 1% open enrollment, not the therapeutic-area sidebar.
University of New Mexico sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 168 trials (± recruiting share)
- Astellas Pharma Global Development · 168 trials · 11% recruiting
- Bausch Health Americas · 168 trials · 4% recruiting
- Seattle Children's Hospital · 168 trials · 17% recruiting
- Sumitomo Pharma America · 168 trials · 4% recruiting
Sponsors near 1% open enrollment (± trial volume)
- Astellas Pharma · 1% recruiting · 165 trials
- Abbott Nutrition · 1% recruiting · 89 trials
- Baxalta now part of Shire · 1% recruiting · 74 trials
- Power Life Sciences · 2% recruiting · 62 trials
Related
What to do with this University of New Mexico page
168 registered trials is a research-attention snapshot, not an endorsement of University of New Mexico or any single study.
- 2 of University of New Mexico's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of New Mexico pipeline card: 168 registered trials from official public datasets.Report a data error.